177 related articles for article (PubMed ID: 344289)
1. Radiotherapy and chemotherapy in combined clinical trials: problems and promise.
Muggia FM; Cortes-Funes H; Wasserman TH
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):161-71. PubMed ID: 344289
[No Abstract] [Full Text] [Related]
2. Recent trends in chemotherapy of solid tumors.
Oberfield RA
Med Clin North Am; 1975 Mar; 59(2):399-409. PubMed ID: 163943
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in prevention of the recurrence of resectable cancer.
Bonadonna G; Tancini G; Rossi A; Gasparini M
Annu Rev Med; 1978; 29():149-75. PubMed ID: 206184
[No Abstract] [Full Text] [Related]
4. Chemotherapy of solid tumours.
World Health Organ Tech Rep Ser; 1977; (605):1-106. PubMed ID: 407727
[No Abstract] [Full Text] [Related]
5. Blood and neoplastic diseases. Management of solid tumours-surgery, radiotherapy, and chemotherapy.
McElwain TJ; Peckham MJ
Br Med J; 1974 Dec; 4(5945):645-7. PubMed ID: 4374290
[No Abstract] [Full Text] [Related]
6. [On intra-arterial antineoplastic chemotherapy].
Caldarola L; Badellino F; Fariello R; Masaracchia S; Lesca F; Reali R
Cancro; 1970; 23(4):199-240. PubMed ID: 5523780
[No Abstract] [Full Text] [Related]
7. Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy.
Carter SK; Soper WT
Cancer Treat Rev; 1974 Mar; 1(1):1-13. PubMed ID: 4534592
[No Abstract] [Full Text] [Related]
8. Re-evaluation of methotrexate as an anticancer drug.
Sullivan RD; Miller E; Zurek WZ; Oberfield RA; Ojima Y
Surg Gynecol Obstet; 1967 Oct; 125(4):819-24. PubMed ID: 6041727
[No Abstract] [Full Text] [Related]
9. [High-dose chemotherapy in nonhematologic tumors].
Espinosa Arranz E; González Barón M
Rev Clin Esp; 2001 Feb; 201(2):93-4. PubMed ID: 11345614
[No Abstract] [Full Text] [Related]
10. [Medical therapy of tumors. II].
Cerimele E
Clin Ter; 1979 Nov; 91(3):279-314. PubMed ID: 397032
[No Abstract] [Full Text] [Related]
11. Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial.
Carter SK
J Natl Cancer Inst; 1976 Aug; 57(2):235-44. PubMed ID: 794496
[No Abstract] [Full Text] [Related]
12. Clinical trials referral resource. Clinical trials with taxol.
Cheson BD
Oncology (Williston Park); 1992 Mar; 6(3):67-70. PubMed ID: 1348954
[No Abstract] [Full Text] [Related]
13. Taxanes in combined-modality therapy for solid tumors.
Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):23-38. PubMed ID: 10550824
[TBL] [Abstract][Full Text] [Related]
14. Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.
Clarysse A; Kenis Y; Mathe G
Recent Results Cancer Res; 1976; (53):1-552. PubMed ID: 189368
[No Abstract] [Full Text] [Related]
15. Significant factors in red cell mass changes after fractionated local radiotherapy.
Levitt SH; Brandt EN; Bogardus CR
Acta Radiol Ther Phys Biol; 1969 Jun; 8(3):199-207. PubMed ID: 4980754
[No Abstract] [Full Text] [Related]
16. Combined 5-fluorouracil and vinblastine therapy for gastrointestinal and other solid tumors.
al-Sarraf M; Vaughn CB; Reed ML; Vaitkevicious VK
Oncology; 1972; 26(2):99-113. PubMed ID: 5049925
[No Abstract] [Full Text] [Related]
17. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
Natale D; Orlando D
Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
[No Abstract] [Full Text] [Related]
18. Thallium-201 imaging in the assessment of tumor response to anti-tumor treatments.
Berk F; Demir H; Aktolun C
Q J Nucl Med; 2003 Mar; 47(1):63-74. PubMed ID: 12714957
[TBL] [Abstract][Full Text] [Related]
19. Cancer chemotherapy.
Smith LH
Major Probl Intern Med; 1971; 1():1-197. PubMed ID: 5005758
[No Abstract] [Full Text] [Related]
20. Irinotecan and radiation in combined-modality therapy for solid tumors.
Choy H; MacRae R
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):22-8. PubMed ID: 11497228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
